0001104659-20-134929.txt : 20201211 0001104659-20-134929.hdr.sgml : 20201211 20201211205909 ACCESSION NUMBER: 0001104659-20-134929 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201209 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUYER DAVID R CENTRAL INDEX KEY: 0001277476 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 201384894 MAIL ADDRESS: STREET 1: ONE PENN PLAZA, 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 35TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 35TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 tm2038354-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2020-12-09 0 0001410939 IVERIC bio, Inc. ISEE 0001277476 GUYER DAVID R C/O IVERIC BIO, INC. ONE PENN PLAZA, 35TH FLOOR NEW YORK NY 10119 1 1 0 0 Executive Chairman Common Stock 2020-12-09 4 M 0 17813 A 71785 D Common Stock 2020-12-10 4 S 0 9602 6.96 D 62183 D Restricted Stock Units 2020-12-09 4 A 0 17813 0 D Common Stock 17813 53437 D Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units. Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 9, 2020. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $6.83 to $7.05 on December 10, 2020 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range. On December 9, 2019, the Reporting Person was granted an award of 71,250 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan. /s/ Todd Anderman, as Attorney-in-Fact for David R. Guyer 2020-12-11